Cargando…
Serum IGFBP7 levels associate with insulin resistance and the risk of metabolic syndrome in a Chinese population
Metabolic syndrome (MetS), one of the major public health concerns, is regarded as the “common soil” of incidence of common chronic diseases and may increase the risk of type 2 diabetes. The predominant underlying mechanism of MetS is insulin resistance (IR). Additionally, previous studies have indi...
Autores principales: | Liu, Yi, Wu, Minliang, Ling, Jie, Cai, Libing, Zhang, Dandan, Gu, Harvest F, Wang, Hao, Zhu, Yimin, Lai, Maode |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4650783/ https://www.ncbi.nlm.nih.gov/pubmed/25984973 http://dx.doi.org/10.1038/srep10227 |
Ejemplares similares
-
Evaluation of IGFBP-7 DNA methylation changes and serum protein variation in Swedish subjects with and without type 2 diabetes
por: Gu, Harvest F, et al.
Publicado: (2013) -
Interaction between IGFBP7 and insulin: a theoretical and experimental study
por: Ruan, Wenjing, et al.
Publicado: (2016) -
Serum levels of IGFBP7 are elevated during acute exacerbation in COPD patients
por: Ruan, Wenjing, et al.
Publicado: (2017) -
HSP60, a protein downregulated by IGFBP7 in colorectal carcinoma
por: Ruan, Wenjing, et al.
Publicado: (2010) -
Insulin Growth Factor Binding Protein 7 (IGFBP7)-Related Cancer and IGFBP3 and IGFBP7 Crosstalk
por: Jin, Li, et al.
Publicado: (2020)